0.732
0.02 (3.08%)
| Penutupan Terdahulu | 0.710 |
| Buka | 0.710 |
| Jumlah Dagangan | 586,632 |
| Purata Dagangan (3B) | 444,132 |
| Modal Pasaran | 1,997,496 |
| Harga / Jualan (P/S) | 0.160 |
| Harga / Buku (P/B) | 1.53 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 9 Aug 2023 - 14 Aug 2023 |
| Margin Keuntungan | 37.43% |
| Margin Operasi (TTM) | -55.04% |
| EPS Cair (TTM) | 24.38 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 9.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 18.24% |
| Nisbah Semasa (MRQ) | 2.95 |
| Aliran Tunai Operasi (OCF TTM) | 5.06 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.51 M |
| Pulangan Atas Aset (ROA TTM) | -44.19% |
| Pulangan Atas Ekuiti (ROE TTM) | -240.71% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | NovaBay Pharmaceuticals, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | -0.67 |
|
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 0.02% |
| % Dimiliki oleh Institusi | 24.51% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |